Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19-Reference-Cited by-同舟云学术

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

Published:2024-04-04 Issue:13 Volume:390 Page:1186-1195
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Hammond Jennifer¹,Fountaine Robert J.¹,Yunis Carla¹,Fleishaker Dona¹,Almas Mary¹,Bao Weihang¹,Wisemandle Wayne¹,Baniecki Mary Lynn¹,Hendrick Victoria M.¹,Kalfov Veselin¹,Simón-Campos J. Abraham¹^ORCID,Pypstra Rienk¹,Rusnak James M.¹

Affiliation:

1. From Global Product Development, Pfizer, Collegeville, PA (J.H.); Global Product Development, Pfizer, Groton, CT (R.J.F.); Global Product Development, Pfizer, Lake Mary (C.Y.), and Global Product Development, Pfizer, Tampa (J.M.R.) — both in Florida; Global Product Development, Pfizer, Lexington, KY (D.F.); Global Product Development, Pfizer, New York (M.A., W.B., R.P.); Global Product Development, Pfizer, Lake Forest, IL (W.W.); Early Clinical Development, Pfizer, Cambridge, MA (M.L.B.); Pfizer,...

Funder

Pfizer

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2309003

Reference16 articles.

1. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis

2. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

3. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

4. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

5. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe;ChemMedChem;2024-09-12

2. Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations;Angewandte Chemie;2024-09-03

3. Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations;Angewandte Chemie International Edition;2024-09-02

4. Antiviral therapy for COVID-19;COVID-19: An Update;2024-09-01

5. Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions;Infectious Diseases and Therapy;2024-08-03